Perigon Pharmacy
Perigon Pharmacy 360 is an independent, dual-accredited (URAC and ACHC) specialty pharmacy dispensing complex and rare-disease therapies nationwide via manufacturer limited distribution networks, supported by its proprietary Medesto adherence and care-coordination platform.
- Company typePrivate
- Founded2017
- HeadquartersCoraopolis, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Perigon Pharmacy does
Perigon Pharmacy 360 is an independent, dual-accredited (URAC and ACHC) specialty pharmacy that dispenses high-cost, complex therapies for patients with rare and chronic conditions including Duchenne muscular dystrophy, hemophilia A, HIV/AIDS, hepatitis C, ADHD, chronic kidney disease, sickle cell disease, and various cancers. The company is licensed in all 50 US states, the District of Columbia, and Puerto Rico, and operates from headquarters in Coraopolis, Pennsylvania with an additional dispensing location in Thousand Oaks, California. It is a division of Perigon Health 360, LLC, which was formed on June 3, 2021, through the merger of Michigan-based Lifeboost, Inc. and Pennsylvania-based Pharmacy Valeda Rx.
The company's core technology is the proprietary Medesto platform — an enterprise remote therapy management system that integrates digital medication dispensing devices (Spencer SmartHub, Adherium Hailie digital inhalers), EHR data aggregation (via Seqster), biometric wearables, and a HIPAA-compliant patient communication layer (Medesto Pulse) to capture longitudinal adherence and clinical data. Perigon has also invested in ultra-low temperature (-80°C) freezer capability to support cell and gene therapy distribution. It reports patient adherence rates exceeding 85% (vs. ~55% industry average) and a Net Promoter Score of 82%.
Perigon's business model combines specialty pharmacy dispensing (transaction-fee reimbursement from health plans, PBMs, and patient insurance), contracted patient support program services for pharmaceutical manufacturers, and data-driven utilization management reporting for payors. The go-to-market is B2B2C: Perigon is selected into manufacturer limited distribution networks (LDNs) for drugs such as HEMLIBRA, XPHOZAH, NUZYRA, DYANAVEL XR, and generic deflazacort, and is contracted with health plans and PBMs as an in-network dispensing channel. Distribution occurs through direct-to-patient home delivery, direct-to-provider office delivery, and digital enrollment via the Medesto platform.
Perigon Pharmacy firmographics
Firmographics- Name
- Perigon Pharmacy
- Legal name
- Perigon Health 360, LLC
- Website
- https://perigonpharmacy.org
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Perigon Pharmacy 360 is an independent, dual-accredited (URAC and ACHC) specialty pharmacy dispensing complex and rare-disease therapies nationwide via manufacturer limited distribution networks, supported by its proprietary Medesto adherence and care-coordination platform.
- Ownership category
- akta.pro rank
Perigon Pharmacy industry classification
Industry- Product category
- Specialty Pharmacy Services
- NAICS
- Pharmacies and Drug Retailers (456110), Pharmacy Benefit Management and Other Third Party Administration of Insurance and Pension Funds (524292)
- SIC
- Retail-Drug Stores And Proprietary Stores (5912)
- akta.pro primary industry
- Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)
Keywords
Where Perigon Pharmacy is headquartered
LocationHeadquarters
- HQ city
- Coraopolis
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Perigon Pharmacy business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- Specialty Pharmacy Dispensing: Perigon Pharmacy 360 generates revenue by dispensing specialty and rare disease medications directly to patients. The pharmacy handles complex, high-cost therapies and earns revenue through prescription reimbursement from health plans, PBMs, and patients' insurance. Revenue is driven by prescription volume and the complexity/specialty nature of medications dispensed.
- Patient Support Program Services: The company provides specialized patient support programs for pharmaceutical manufacturer partners, including adherence monitoring, reimbursement assistance, and direct-to-patient delivery programs. These programs generate revenue through contractual arrangements with bio pharma companies.
- Payor and PBM Data Services: Perigon provides data-driven utilization management, adherence reporting, and analytics to health plans and PBMs, helping them control costs while maintaining care standards. Revenue flows from contracted payor relationships.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Patient prescription services — pricing not publicly disclosed |
Go-to-market motion3 records
Distribution channels4 records
Marketing channels5 records
Perigon Pharmacy product offering
Product offeringCore offering
Perigon Pharmacy 360 is an independent specialty pharmacy that dispenses and manages high-cost specialty and rare disease medications for patients with complex chronic conditions. The company combines its proprietary Medesto digital health platform with high-touch clinical care teams to deliver nationwide medication dispensing, adherence monitoring, prior authorization support, financial assistance, and cold-chain logistics including ultra-low temperature cell and gene therapy handling. It operates through direct-to-patient home delivery, prescriber office delivery, limited distribution networks for pharmaceutical manufacturers, and contracted payor relationships with health plans and PBMs across all 50 states plus DC and Puerto Rico.
Product overview
Perigon Pharmacy operates as a Precision Digital Pharmacy combining the Medesto enterprise technology platform with specialty pharmacy services. The core offering includes the Medesto Platform (remote therapy management connecting devices, EHRs, and monitoring tools), Medesto Pulse (patient communication app), Medesto Go (portable digital health device), and Medesto Messenger (provider communication tool), all integrated with specialty pharmacy care. The company provides cell and gene therapy capabilities with ultra-low temperature storage, and partners with pharmaceutical manufacturers for limited distribution networks.
Differentiator
Problem solved
Functional benefit
Brands
- Medesto: Enterprise remote therapy management platform for medication adherence monitoring, patient engagement, and clinical intelligence.
- Medesto Pulse
- Medesto Go
- Medesto Messenger
- Spencer SmartHub
Products and services
- Perigon Pharmacy 360 Specialty Pharmacy Services Independent specialty pharmacy dispensing high-cost specialty and rare disease medications (e.g., for hemophilia A, Duchenne muscular dystrophy, chronic kidney disease, ADHD, hepatitis C, HIV/AIDS, sickle cell disease, rheumatoid arthritis, and various cancers) with personalized patient care, insurance advocacy, financial assistance navigation, and direct home delivery across all 50 states plus DC and Puerto Rico.
Quantifiable outcome
- Net Promoter Score (NPS) of 82% — classified as 'World Class' patient satisfaction, compared to industry average of 30-50%
- +4 more outcomes
Companies that use Perigon Pharmacy
Customer profileNamed customers5 records
Segments4 records
Ideal customer profiles4 records
Perigon Pharmacy technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
Feature7 records
Perigon Pharmacy partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered major and core.
- GenentechmajorPerigon Pharmacy 360 was selected to join Genentech's Limited Distribution Network for HEMLIBRA (emicizumab-kxwh), the only subcutaneous injection for hemophilia A with or without factor VIII inhibitors. This extends Perigon's rare disease pharmacy capabilities to include hemophilia patients requiring routine prophylaxis.
- Cranbury PharmaceuticalsmajorPerigon Pharmacy 360 was named the exclusive specialty pharmacy provider for the newly released generic deflazacort oral suspension for Duchenne muscular dystrophy treatment. Perigon provides comprehensive patient support including insurance advocacy, convenient delivery, treatment adherence programs, bridge medication supply, and financial aid programs through Cranbury Connects.
- Paratek PharmaceuticalsmajorPerigon Pharmacy 360 was selected to join Paratek's Limited Distribution Network for NUZYRA (omadacycline), a novel antibiotic for community-acquired bacterial pneumonia and acute bacterial skin infections. This strategic partnership aligns with Perigon's mission to provide innovative healthcare solutions and provides patients with timely access to this groundbreaking medication.
- ArdelyxmajorPerigon Pharmacy 360 was selected to participate in Ardelyx's Limited Distribution Network for XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor for adults with chronic kidney disease. Perigon's proven track record in handling complex specialty medications and adherence to highest quality and patient care standards made it an ideal partner.
- Tris PharmamajorPerigon Pharmacy 360 partnered with Tris Pharma to launch the DYANAVEL Delivered direct-to-patient program for DYANAVEL XR extended-release tablets (amphetamine) for ADHD treatment. Perigon provides digital pharmacy services, medication management, reimbursement assistance, and nationwide direct delivery, helping eliminate bottlenecks in ADHD medication access.
- Spencer Health SolutionscorePerigon Pharmacy 360 signed a collaboration agreement with Spencer Health Solutions to expand the reach of SHS' innovative in-home digital medication adherence technology (spencer SmartHub). The FDA-certified Class 1 medical device dispenses pre-packaged medications, promotes adherence, and collects longitudinal daily patient insights. Patients enrolled in the Spencer program exhibit 97% daily medication adherence. Perigon also joined the Spencer-Certified Pharmacy Partner Network.
- Ardelyx (ArdelyxAssist Patient Assistance Program)corePerigon Pharmacy 360 partnered with ArdelyxAssist patient assistance program to provide a broad range of access and affordability support for patients prescribed Ibsrela (Tenapanor) for IBS-C. Perigon dispenses the medication while ArdelyxAssist provides financial and access support.
- AdheriumcorePerigon Health 360 incorporated Adherium's Hailie digital inhaler sensor technology into the Medesto Drug and Therapy Monitoring Platform. The Hailie solution includes sensor technology and cloud-based data platform for optimally managing patients with severe asthma and COPD, increasing adherence to preventative medication by 180% in children and 59% in adults, and reducing severe exacerbations in adults by 60%. The effectiveness has been demonstrated in 42 clinical trials involving over 14,000 patients.
- Seqster PDM Inc.corePerigon Health 360 partnered with Seqster to integrate its patient-centric healthcare data technology into the Precision Digital Pharmacy platform. The partnership provides a real-time 360-degree patient view across multiple provider EHRs and remote monitoring devices, enabling remote dispensing of the right medication at the right time. It reduces time and cost of medical record collection and allows patients and caregivers to access vital medication regimen information to support adherence.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
Perigon Pharmacy competitors and assessment
Company assessmentDirect peers
- Soleo Health: Specialty pharmacy and home infusion provider focused on complex patient populations including rare disease, oncology, and chronic conditions. Comparable in size and similar in targeting specialty therapy patients with high-touch service and multiple LDN relationships.
- AcariaHealth: Specialty pharmacy co-founded by Perigon's Chairman Don Howard before sale to Centene. Operates a nearly identical model: complex specialty therapy dispensing, payor/PBM contracting, LDN participation, and rare disease focus. Closest historical and operational analog to Perigon.
- Biologics by McKesson: Independent specialty pharmacy within McKesson focused on oncology and complex conditions. Comparable business model with LDN partnerships, payor contracts, and adherence support programs, though backed by McKesson's distribution scale.
- PANTHERx Rare Pharmacy: Independent specialty pharmacy focused exclusively on rare and orphan diseases. Most direct competitor to Perigon's core model: high-touch specialty pharmacy with multiple LDN partnerships and adherence technology, targeting identical patient populations with hemophilia, Duchenne, and other rare conditions.
- CuraScript SD (Express Scripts): Specialty distribution arm co-founded by Perigon's Chairman Don Howard before its sale to Express Scripts in 2004. Closest historical peer and continues to operate in the same LDN and limited distribution drug distribution space as Perigon.
- Orsini Specialty Pharmacy: Independent specialty pharmacy focused on rare diseases and specialty therapeutics, with strong LDN participation in hemophilia, immunodeficiency, and other complex therapy areas. Closely comparable in size, accreditation profile, and target patient populations.
Broad incumbents
- CVS Specialty (Caremark): Specialty pharmacy arm of CVS Health serving complex patient populations through retail and digital channels. Largest competitor by patient volume and the entity most likely to disintermediate independent specialty pharmacies through captive PBM steering.
- Diplomat Pharmacy (Optum Specialty Pharmacy): Originally an independent specialty pharmacy leader in rare/orphan disease dispensing, acquired by Optum (UnitedHealth Group) in 2020. Represents the scaled incumbent path Perigon would be competing against in the rare disease specialty pharmacy space.
- Accredo (Express Scripts / Cigna): Specialty pharmacy division of Evernorth/Cigna serving complex and chronic conditions including hemophilia, oncology, and rare diseases. Largest scaled competitor with vertically integrated PBM relationships that compete for the same LDN partnerships and payor contracts.
- US Bioservices (PharmaLex / AmerisourceBergen): Specialty pharmacy within Cencora (formerly AmerisourceBergen) offering complex therapy management for rare disease, oncology, and chronic conditions. Comparable business model and patient population, with significant distribution backing.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Perigon Pharmacy social profiles
Digital presencePerigon Pharmacy compliance and trust
Trust signalCompliance3 records
Perigon Pharmacy financial estimates
Financial estimateRevenue estimate
Valuation estimate
Perigon Pharmacy leadership team
Management profileNumber of profiles
Profiles6 records
Perigon Pharmacy funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Perigon Pharmacy M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Perigon Pharmacy
What does Perigon Pharmacy do?
Perigon Pharmacy 360 is an independent specialty pharmacy that dispenses and manages high-cost specialty and rare disease medications for patients with complex chronic conditions. The company combines its proprietary Medesto digital health platform with high-touch clinical care teams to deliver nationwide medication dispensing, adherence monitoring, prior authorization support, financial assistance, and cold-chain logistics including ultra-low temperature cell and gene therapy handling. It operates through direct-to-patient home delivery, prescriber office delivery, limited distribution networks for pharmaceutical manufacturers, and contracted payor relationships with health plans and PBMs across all 50 states plus DC and Puerto Rico.
Is Perigon Pharmacy a public or private company?
Perigon Pharmacy is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Perigon Pharmacy founded?
Perigon Pharmacy was founded in 2017. It employs 11 to 50 people.
Where is Perigon Pharmacy based?
Perigon Pharmacy is headquartered in Coraopolis, United States, in the North America region.
How does Perigon Pharmacy make money?
Three revenue lines are on record. Specialty Pharmacy Dispensing is the primary driver. The others are patient Support Program Services and payor and PBM Data Services.
Who are Perigon Pharmacy's main competitors?
Direct peers on record are Soleo Health, AcariaHealth, Biologics by McKesson, PANTHERx Rare Pharmacy, CuraScript SD (Express Scripts) and Orsini Specialty Pharmacy. Broad incumbents are CVS Specialty (Caremark), Diplomat Pharmacy (Optum Specialty Pharmacy), Accredo (Express Scripts / Cigna) and US Bioservices (PharmaLex / AmerisourceBergen).
Does Perigon Pharmacy have an API?
No public API is recorded for Perigon Pharmacy.
What industry is Perigon Pharmacy in?
Perigon Pharmacy's product category is Specialty Pharmacy Services. Its primary akta.pro industry code is HLACAKAG, Specialty Pharmacy & Complex Therapy Management Platforms. Its NAICS code is 456110 and its SIC code is 5912.